Tiffany Lucas PhD U.S. FDA
Tiffany Lucas PhD U.S. FDA Gene Therapy Senior CMC Reviewer, OTP, CBER
Dr. Tiffany Lucas joined FDA in 2018 and is a Senior Gene Therapy Reviewer. Most recently, she spent time in the Center for Biologics Office of the Director as a Regulatory Operations Senior Advisor. She works on all lifecycle stages with gene therapy products, including commercial, BLA, IND, and preIND phases. Her interests include ex vivo modified cellular gene therapy products, lentiviral vector engineering, and rare disease. Prior to joining the FDA, Dr. Lucas was an investment analyst for a biotech group focused on each stage biotechnology development and she also worked in technology evaluation, IP, and licensing. She completed postdoctoral studies at Washington University-St. Louis Medical School studying virus-immune interactions and earned her PhD at University of Missouri for her research on retroviral vector engineering.